&Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Buy
34,021
+2,548
+8% +$1.11M 0.06% 310
2026
Q1
$14.5M Buy
31,473
+1,798
+6% +$910K 0.07% 257
2025
Q4
$16.8M Buy
29,675
+5,783
+24% +$3.08M 0.09% 204
2025
Q3
$10.7M Buy
23,892
+1,212
+5% +$582K 0.07% 252
2025
Q2
$12.3M Buy
22,680
+7,883
+53% +$4.12M 0.09% 209
2025
Q1
$7.14M Sell
14,797
-264
-2% -$146K 0.08% 238
2024
Q4
$8.06M Buy
15,061
+3,833
+34% +$2M 0.1% 205
2024
Q3
$5.52M Buy
11,228
+7,105
+172% +$3.31M 0.11% 191
2024
Q2
$1.83M Buy
4,123
+3,390
+462% +$1.35M 0.08% 224
2024
Q1
$293K Buy
+733
New +$277K 0.04% 371

Other funds holding ISRG

&Partners's ISRG Position: Q2 2026 in Review

&Partners increased its Intuitive Surgical (ISRG) stake by 8.1% in Q2 2026, buying an estimated $1.11M and bringing the position to 34,021 shares worth $13.5M. The position accounts for 0.06% of the portfolio, ranked #310.

&Partners first reported a position in ISRG in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.8M in Q4 2025. 2,258 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • &Partners held 34,021 shares of Intuitive Surgical worth $13.5M as of Q2 2026.
  • &Partners bought 2,548 Intuitive Surgical shares in Q2 2026, an estimated $1.11M.
  • Intuitive Surgical made up 0.06% of &Partners's portfolio in Q2 2026, its #310 holding.
  • &Partners first reported a position in Intuitive Surgical in Q1 2024 and has held it in 10 quarters since.
  • &Partners's Intuitive Surgical position peaked at $16.8M in Q4 2025.
  • 2,258 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.